1-4 of 4
Mark C. Valentine
Close
Sort by
Journal Articles

Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4

Brief Report
J. Philip Creamer, Carissa Dege, Qihao Ren, Jolie T. K. Ho, Mark C. Valentine, Todd E. Druley, Christopher M. Sturgeon
Journal: Blood
Blood (2017) 129 (22): 2988–2992.
https://doi.org/10.1182/blood-2016-11-749382
Published: 2017
Includes: Supplemental data
Journal Articles

Human Definitive Hematopoietic Specification from Pluripotent Stem Cells Is Regulated By Mesodermal Expression of CDX4

John Philip Creamer, B.Sc., Carissa Dege, PhD, Jolie T.K. Ho, Qihao Ren, Mark C Valentine, BS, Christopher Michael Sturgeon, PhD
Journal: Blood
Blood (2016) 128 (22): 883.
https://doi.org/10.1182/blood.V128.22.883.883
Published: 2016
Journal Articles

Infants with Leukemia Exhibit Compound Heterozygosity for Deleterious Germline Variation in MLL3 Independent of MLL-Rearrangements

Mark C Valentine, BS, Elizabeth L Ostrander, BS, Amy Linabery, PhDMS, Logan G. Spector, PhD, Julie A. Ross, PhD, Todd E Druley, MDPhD
Journal: Blood
Blood (2014) 124 (21): 485.
https://doi.org/10.1182/blood.V124.21.485.485
Published: 2014
Journal Articles

Germline Exome Sequencing From MLL -Negative Infant AML Patients Reveals Compound Heterozygosity For Novel, Non-Synonymous Alleles Of MLL3 : A Report From The Children’s Oncology Group (COG)

Mark C. Valentine, Amy M. Linabery, PhD, MS, Logan G. Spector, PhD, Julie A Ross, PhD, Todd E Druley, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 62.
https://doi.org/10.1182/blood.V122.21.62.62
Published: 2013